Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Brazil
/
Healthcare
/
Hapvida Participações e Investimentos
HAPV3
Hapvida Participações e Investimentos
Digital Transformation And Brazil's Demographics Will Expand Private Healthcare
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
02 Jul 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
R$83.53
56.7% undervalued
intrinsic discount
23 Jul
R$36.17
Loading
1Y
-45.6%
7D
10.7%
Author's Valuation
R$83.5
56.7% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
R$83.5
56.7% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-2b
42b
2014
2017
2020
2023
2025
2026
2028
Revenue R$42.1b
Earnings R$3.4b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
7.36%
Healthcare Services revenue growth rate
0.30%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
18.26%
Calculation
R$3.45b
Earnings '28
x
19.12x
PE Ratio '28
=
R$65.90b
Market Cap '28
R$65.90b
Market Cap '28
/
480.06m
No. shares '28
=
R$137.28
Share Price '28
R$137.28
Share Price '28
Discounted to 2025 @ 18.02% p.a.
=
R$83.52
Fair Value '25